AMGN
Price
$377.35
Change
-$5.12 (-1.34%)
Updated
Sep 11 closing price
Capitalization
204.01B
52 days until earnings call
Intraday BUY SELL Signals
BIIB
Price
$217.15
Change
+$1.72 (+0.80%)
Updated
Sep 11 closing price
Capitalization
32.08B
47 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AMGN vs BIIB

AMGN vs BIIB Comparison Chart in %
View a ticker or compare two or three
VS
AMGN vs. BIIB commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMGN is a Hold and BIIB is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMGN($204B) has a higher market cap than BIIB($32.1B). BIIB has higher P/E ratio than AMGN: BIIB (38.57) vs AMGN (23.44). BIIB YTD gains are higher at: 23.388 vs. AMGN (17.647). AMGN has higher annual earnings (EBITDA): 17.6B vs. BIIB (2.14B). AMGN has more cash in the bank: 14B vs. BIIB (1.29B). BIIB has less debt than AMGN: BIIB (8.36B) vs AMGN (57.3B). AMGN has higher revenues than BIIB: AMGN (38.1B) vs BIIB (10B).
AMGNBIIBAMGN / BIIB
Capitalization204B32.1B636%
EBITDA17.6B2.14B823%
Gain YTD17.64723.38875%
P/E Ratio23.4438.5761%
Revenue38.1B10B381%
Total Cash14B1.29B1,089%
Total Debt57.3B8.36B686%
FUNDAMENTALS RATINGS
AMGN vs BIIB: Fundamental Ratings
AMGN
BIIB
OUTLOOK RATING
1..100
6788
VALUATION
overvalued / fair valued / undervalued
1..100
7
Undervalued
76
Overvalued
PROFIT vs RISK RATING
1..100
14100
SMR RATING
1..100
1584
PRICE GROWTH RATING
1..100
4723
P/E GROWTH RATING
1..100
355
SEASONALITY SCORE
1..100
5065

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AMGN's Valuation (7) in the Biotechnology industry is significantly better than the same rating for BIIB (76). This means that AMGN’s stock grew significantly faster than BIIB’s over the last 12 months.

AMGN's Profit vs Risk Rating (14) in the Biotechnology industry is significantly better than the same rating for BIIB (100). This means that AMGN’s stock grew significantly faster than BIIB’s over the last 12 months.

AMGN's SMR Rating (15) in the Biotechnology industry is significantly better than the same rating for BIIB (84). This means that AMGN’s stock grew significantly faster than BIIB’s over the last 12 months.

BIIB's Price Growth Rating (23) in the Biotechnology industry is in the same range as AMGN (47). This means that BIIB’s stock grew similarly to AMGN’s over the last 12 months.

BIIB's P/E Growth Rating (5) in the Biotechnology industry is in the same range as AMGN (35). This means that BIIB’s stock grew similarly to AMGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMGNBIIB
RSI
ODDS (%)
Bullish Trend 2 days ago
61%
Bearish Trend 2 days ago
70%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
59%
Bullish Trend 2 days ago
52%
Momentum
ODDS (%)
Bearish Trend 2 days ago
43%
Bearish Trend 2 days ago
74%
MACD
ODDS (%)
Bearish Trend 2 days ago
38%
Bearish Trend 2 days ago
64%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
50%
Bearish Trend 2 days ago
71%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
46%
Bullish Trend 2 days ago
63%
Advances
ODDS (%)
Bullish Trend 10 days ago
61%
Bullish Trend 2 days ago
58%
Declines
ODDS (%)
Bearish Trend 2 days ago
47%
Bearish Trend 4 days ago
69%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
65%
Bearish Trend 2 days ago
73%
Aroon
ODDS (%)
Bullish Trend 2 days ago
57%
Bullish Trend 2 days ago
60%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (AMGN: $377.35 vs. BIIB: $217.15)
Brand notoriety: AMGN and BIIB are both notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: AMGN: 93% vs. BIIB: 97%
Market capitalization -- AMGN: $204.01B vs. BIIB: $32.08B
AMGN [@Pharmaceuticals: Major] is valued at $204.01B. BIIB’s [@Pharmaceuticals: Major] market capitalization is $32.08B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $72.83K to $994.49B. The average market capitalization across the [@Pharmaceuticals: Major] industry is $193.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMGN’s FA Score shows that 3 FA rating(s) are green while BIIB’s FA Score has 2 green FA rating(s).

  • AMGN’s FA Score: 3 green, 2 red.
  • BIIB’s FA Score: 2 green, 3 red.
According to our system of comparison, AMGN is a better buy in the long-term than BIIB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMGN’s TA Score shows that 5 TA indicator(s) are bullish while BIIB’s TA Score has 3 bullish TA indicator(s).

  • AMGN’s TA Score: 5 bullish, 4 bearish.
  • BIIB’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, AMGN is a better buy in the short-term than BIIB.

Price Growth

AMGN (@Pharmaceuticals: Major) experienced а -13.70% price change this week, while BIIB (@Pharmaceuticals: Major) price change was -1.67% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -4.36%. For the same industry, the average monthly price growth was -3.99%, and the average quarterly price growth was +5.78%.

Reported Earning Dates

AMGN is expected to report earnings on Nov 03, 2026.

BIIB is expected to report earnings on Oct 29, 2026.

Industries' Descriptions

@Pharmaceuticals: Major (-4.36% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

View a ticker or compare two or three
AMGN
Daily Signal:
Gain/Loss:
BIIB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
YI3.570.26
+7.85%
111 Inc
MUFG23.890.60
+2.58%
Mitsubishi UFJ Financial Group
SFM72.760.56
+0.78%
Sprouts Farmers Market
APPS11.810.01
+0.08%
Digital Turbine
BPRN43.35-0.24
-0.55%
Princeton Bancorp

AMGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMGN has been loosely correlated with BIIB. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if AMGN jumps, then BIIB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMGN
1D Price
Change %
AMGN100%
-1.34%
BIIB - AMGN
62%
Loosely correlated
+0.80%
PFE - AMGN
53%
Loosely correlated
+0.25%
GILD - AMGN
52%
Loosely correlated
-0.75%
MRK - AMGN
48%
Loosely correlated
-0.54%
ABBV - AMGN
48%
Loosely correlated
+0.83%
More

BIIB and

Correlation & Price change

A.I.dvisor indicates that over the last year, BIIB has been loosely correlated with AMGN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if BIIB jumps, then AMGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIIB
1D Price
Change %
BIIB100%
+0.80%
AMGN - BIIB
49%
Loosely correlated
-1.34%
AZN - BIIB
49%
Loosely correlated
+0.33%
PFE - BIIB
48%
Loosely correlated
+0.25%
MRK - BIIB
47%
Loosely correlated
-0.54%
ABBV - BIIB
41%
Loosely correlated
+0.83%
More